dermveda ULTRA Dark Spot Remedy Serum

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: dermveda ULTRA Dark Spot Remedy Serum
Generic name: GLYCYRRHIZA GLABRA, CURCUMA LONGA
Manufacturer: Celcius Corp.
Product type: HUMAN OTC DRUG
SPL set ID: 7367a870-fc0e-4e13-a9f3-5b0064956c38
SPL ID: ae62dcef-c5a4-4073-9e47-4ae0a9a5bd97
Version: 1
Effective date: 2026-03-18
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:12:30

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		dermveda ULTRA Dark Spot Remedy Serum	openfda.brand_name
generic name		GLYCYRRHIZA GLABRA, CURCUMA LONGA	openfda.generic_name
manufacturer name		Celcius Corp.	openfda.manufacturer_name
ndc	package	83819-609-02	openfda.package_ndc
ndc	product	83819-609	openfda.product_ndc
ndc11	package	83819060902	derived:openfda.package_ndc
spl id		ae62dcef-c5a4-4073-9e47-4ae0a9a5bd97	id
spl set id		7367a870-fc0e-4e13-a9f3-5b0064956c38	set_id
unii		2788Z9758H	openfda.unii
unii		856YO1Z64F	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use • on children under 2 years of age unless directed by a doctor • Avoid contact with eyes. When using this product • mild increase in irritation or burning may occur. Stop use and ask a doctor if • Symptoms persist or inflammation increases after weeks of use or if the itch increases. • Increase in redness on skin. Pregnant or Breast Feeding • Ask a Health Professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.